Clinical Trials Logo

Arteriosclerosis clinical trials

View clinical trials related to Arteriosclerosis.

Filter by:

NCT ID: NCT00930813 Completed - Atherosclerosis Clinical Trials

LEVANT I, The Lutonix Paclitaxel-Coated Balloon for the Prevention of Femoropopliteal Restenosis

LEVANT I
Start date: June 2009
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of the study is to assess the safety and efficacy of the Lutonix Catheter for treatment of stenosis of the femoropopliteal arteries by direct comparison to standard balloon angioplasty.

NCT ID: NCT00925561 Completed - Atherosclerosis Clinical Trials

Examining the Genetic Predictors of Coronary Artery Calcification in African Americans

Start date: January 2009
Phase: N/A
Study type: Observational

Coronary artery disease (CAD) is an important health concern for African Americans, who are diagnosed with CAD at high rates. Coronary artery calcification, which is characterized by calcium deposits in the coronary arteries, is a contributing factor to CAD. This study will examine the possible genetic causes of coronary artery calcification in African Americans.

NCT ID: NCT00895427 Completed - Diabetes Clinical Trials

A Study Comparing Skin Fluorescence to Coronary Artery Calcification

CACS
Start date: February 2009
Phase: N/A
Study type: Observational

This study examines the relationship between the SCOUT DM device and coronary artery calcification as determined by rapid computed tomography in patients at risk for coronary heart disease.

NCT ID: NCT00860847 Completed - Coronary Stenosis Clinical Trials

Firefighter Aged Garlic Extract Investigation With CoQ10 as a Treatment for Heart Disease (FAITH)

Start date: May 2009
Phase: Phase 3
Study type: Interventional

1. Statement of Problem According to the National Fire Protection Association (NFPA), 43.7% of all firefighters that died on the job experienced sudden cardiac death. The job also affords an incredible amount of stress. Cholesterol therapy has been well demonstrated to reduce coronary plaque progression. However is certainly not the only factor in evaluating for progression of coronary artery disease (CAD), and other factors must play a role. Garlic therapy has been shown to retard atherosclerosis independently. 2. Hypothesis and Specific Aims The hypothesis of this proposal is: In comparison to the placebo group, Aged Garlic Extract (AGE) therapy + Coenzyme Q10 (CoQ10) will be effective in slowing progression of coronary artery calcification (CAC) in firefighters with established atherosclerosis, independent of baseline blood pressure, statin use or other cardiovascular risk factors. Specific Aims: 1. Compare the effects of cholesterol lowering effects in a firefighter population of patients under the influence of Aged Garlic Extract + CoQ10 or placebo. 2. Compare whether degree of change in atherosclerotic coronary artery plaque burden will change at a different rate under the influence of Aged Garlic Extract + CoQ10 compared to placebo treatment. 3. Compare whether Aged Garlic Extract + CoQ10 therapy induces changes in baseline values including biological and biochemical parameters, such as LDL cholesterol, homocysteine, C-reactive protein (CRP), and endothelial function.

NCT ID: NCT00823849 Completed - Clinical trials for Type 2 Diabetes Mellitus

Study of Cilostazol and Probucol to Assess Their Effects on Atherosclerosis Related Biomarker

Start date: October 2008
Phase: Phase 4
Study type: Interventional

1. To evaluate the efficacy of Cilostazol and Probucol alone and in combination on atherosclerosis related biomarker 2. To evaluate the safety of Cilostazol and Probucol alone and in combination on atherosclerosis related biomarker

NCT ID: NCT00764426 Completed - Clinical trials for Myocardial Infarction

Alcohol, Inflammation and Atherosclerosis

Start date: June 2004
Phase: N/A
Study type: Interventional

Effect of moderate alcohol consumption in form of red wine, beer and ethanol solution and corresponding de-alcoholised beverages on immune measures. - In healthy middle aged men and women - In a randomized controlled cross-over trial - Two intervention periods over 3 weeks

NCT ID: NCT00712946 Completed - Clinical trials for Arteriosclerosis Obliterans

Preoperative Heart Rate Variability and Baroreflex Sensitivity in ASO Patients During Various Sleep Stages

Barosleep
Start date: March 2006
Phase: N/A
Study type: Observational

The goal of this study is to evaluate the possible preoperative predictive value of altered heart rate variability (HRV) and baroreflex sensitivity in different sleep stages for postoperative adverse cardiac events (i.e. arrhythmia or myocardial ischemia needing hospitalization or medication, myocardial ischemia assessed by enzyme release, myocardial infarction, sudden cardiac death, stroke) in arteriosclerosis obliterans patients.

NCT ID: NCT00701818 Completed - Ischemic Stroke Clinical Trials

Coronary Arteriosclerosis in Patients With Acute Ischemic Stroke

CORAIS
Start date: May 2008
Phase: N/A
Study type: Observational

The specific objectives of this thesis are in a cohort of patients with an acute ischemic stroke, 1. To establish the degree of coronary arteriosclerosis. 2. To describe left ventricular systolic and diastolic function in relation to changes of NT-proBNP.

NCT ID: NCT00674531 Completed - Arteriosclerosis Clinical Trials

Detection of Enterovirus RNA in Atheromatous Lesions

ATH-ENTE
Start date: January 2008
Phase: N/A
Study type: Interventional

Atherosclerosis is one of the first causes of morbidity-mortality in industrialized countries. Numerous works suggest that some infectious agents could be involved in the inflammatory process leading to the development of this pathology, such as Chlamydophila pneumoniae, cytomegalovirus or herpes simplex virus. Enteroviruses are small RNA viruses that have been incriminated in various acute or chronic cardiac diseases (pericarditis, myocarditis, dilated cardiomyopathy) and exhibit a tropism for vascular endothelia. Different clinical and experimental arguments suggest that they could play a cofactor role in the occurrence or maintenance of atherosclerosis lesions. A multicenter study developed in collaboration with colleagues of the University Hospital of Reims (France) showed that it was frequent to detect enterovirus RNA in cardiac biopsies from patients with myocardial infarction. Furthermore, a pilot study conducted in the University Hospital of Saint-Etienne (France) on atheromatous arterial samples from 18 patients allowed the detection of enterovirus RNA in 20% of them.

NCT ID: NCT00657943 Completed - Type 2 Diabetes Clinical Trials

The Copenhagen Insulin and Metformin Therapy Trial

CIMT
Start date: April 2008
Phase: Phase 4
Study type: Interventional

Type 2 Diabetes Mellitus patients (T2DM) have an increased mortality rate due to macrovascular disease. The primary objective of the study is to evaluate the effect of an 18-month treatment with metformin versus placebo in combination with one of three insulin analogue regimens following a treat-to-target principle. The primary outcome measure is change in wall thickness of the carotic arteries(CIMT)measured by ultrasound. A total of 900 patients with T2DM and HbA1c above 7.5% will be included.